9 results match your criteria: "University of Occupational and Environmental Health 1-1[Affiliation]"
RSC Adv
May 2022
Institute of Advanced Energy, Kyoto University Uji Kyoto 611-0011 Japan
Auto-fluorescent protein (AFP)-based biosensors transduce the structural change in their embedded recognition modules induced by recognition/reaction events to fluorescence signal changes of AFP. The lack of detailed structural information on the recognition module often makes it difficult to optimize AFP-based biosensors. To enhance the signal response derived from detecting the putative structural change in the nitric oxide (NO)-sensing segment of transient receptor potential canonical 5 (TRPC5) fused to enhanced green fluorescent protein (EGFP), EGFP-TRPC5, a facile two-step screening strategy, first and second, was applied to variants of EGFP-TRPC5 deletion-mutated within the recognition module.
View Article and Find Full Text PDFInt J Mol Sci
May 2021
Department of Dermatology, University of Occupational and Environmental Health 1-1, Iseigaoka, Yahatanishi-ku, Kitakyushu, Fukuoka 807-8555, Japan.
Daily lifestyle is a fundamental part of human life and its influence accumulates daily in the human body. We observe that a good daily lifestyle has a beneficial impact on our health; however, the actual effects of individual daily lifestyle factors on human skin diseases, especially skin cancers, have not been summarized. In this review, we focused on the influence of daily lifestyle on the development of skin cancer and described the detailed molecular mechanisms of the development or regulation of cutaneous malignancies.
View Article and Find Full Text PDFInt J Mol Sci
February 2021
Department of Dermatology, University of Occupational and Environmental Health 1-1, Iseigaoka, Yahatanishi-Ku, Kitakyushu 807-8555, Japan.
Melanoma is a severe and life-threatening malignancy derived from melanocytes. The traditional treatment for melanoma could not sustain satisfactory outcomes long term; however, the recent immune checkpoint treatment has made a breakthrough in these problems. Nivolumab is a representative immune checkpoint treatment, and this PD-1-targeted therapy has evolutionally developed and improved the clinical outcome in a recent decade.
View Article and Find Full Text PDFActa Derm Venereol
November 2016
Department of Dermatology, University of Occupational and Environmental Health. 1-1 Iseigaoka, Yahatanishi-ku, Kitakyushu 807-8555, Japan.
Acta Derm Venereol
June 2016
Department of Dermatology, University of Occupational and Environmental Health. 1-1 Iseigaoka, Yahatanishi-ku, Kitakyushu 807-8555, Japan.
Eur J Dermatol
December 2016
Department of Dermatology, University of Occupational and Environmental Health. 1-1 Iseigaoka, Yahatanishi-ku, Kitakyushu 807-8555, Japan.
Acta Derm Venereol
May 2016
Department of Dermatology, University of Occupational and Environmental Health. 1-1 Iseigaoka, Yahatanishi-ku, Kitakyushu 807-8555, Japan.
Int J Urol
December 2003
Department of Urology, University of Occupational and Environmental Health. 1-1 Iseigaoka Yahatanishi-ku, Kitakyushu 807-8555, Japan.
Background: The objective of the study presented here was to assess the usefulness and indications of multiple biopsies of normal-appearing urothelium in patients with superficial bladder cancer.
Methods: Between December 1996 and December 2002, multiple biopsies of normal-appearing bladder mucosa were performed in 100 patients with superficial bladder transitional cell carcinoma. Biopsy specimens were taken from seven different sites in females and nine different sites in males.
Hum Psychopharmacol
August 2003
Department of Psychiatry, School of Medicine, University of Occupational and Environmental Health 1-1 Iseigaoka, Yahatanisi-ku, Kitakyusyu 807-8555, Japan.
This communication describes a patient who developed Schneiderian first-rank symptoms in the course of treatment with fluvoxamine. The patient, a 28-year-old man suffering from panic disorder, developed several first-rank symptoms during fluvoxamine administration. These symptoms abated 1 week after fluvoxamine treatment was discontinued and haloperidol was started.
View Article and Find Full Text PDF